Compound ID | 1246
SMT-571 (DDS-01 Series)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Neisseria gonorrhoeae |
| Institute where first reported: | Summit Therapeutics |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.